Asia-Pacific

Regional website:
www.amfar.org/treatasia

IeDEA Asia-Pacific on PubMed:
Link to Asia-Pacific Publications in PubMed

Annette Sohn, Principal Investigator
amfAR TREAT Asia
Bangkok, Thailand

Matthew Law, Principal Investigator
The Kirby Institute
University of New South Wales
Darlinghurst, NSW, Australia

Countries

  • Australia
  • Cambodia
  • China and Hong Kong SAR
  • India
  • Indonesia
  • Japan
  • Malaysia
  • New Zealand
  • Philippines
  • Singapore
  • South Korea
  • Taiwan
  • Thailand
  • Vietnam

The IeDEA Asia-Pacific Research Collaboration has established a complex network of over 60 clinical centers and research partners that has successfully studied factors driving the epidemic and HIV disease and treatment outcomes, building up the evidence used to guide clinical practice and policy.

The overall scientific goal is to evaluate the impact of HIV disease, co-infections, co-morbidities, and antiretroviral therapy management on short- and long-term clinical and programmatic outcomes in the region, and compare them across the IeDEA global consortium.

This goal is achieved through the study of established regional cohort databases and innovative sub-studies and data resources representing over 84,000 children, adolescents, and adults.  The research program addresses four priority areas:

  • adult HIV disease, treatment, and co-infection outcomes;
  • pediatric and adolescent HIV disease, treatment, and co-infection outcomes;
  • cancer risk, screening, and treatment outcomes; and
  • the impact of stimulant use on HIV risk and treatment outcomes.

IeDEA Asia-Pacific follows a model of shared leadership that prioritizes the engagement of local investigators in the development and implementation of research concepts.  Our work contributes to regional and global understanding of HIV and co-infection outcomes across risk populations and the full age spectrum of people living with HIV in the Asia-Pacific.